Sublingual B12 can be effective for mild deficiency and maintenance
No, but the form matters
Monitoring should include assessment of age, baseline health, coexisting conditions, lifestyle, and concurrent drugs
New England Journal of Medicine, 352(11), 1112-1120
Are insurance and self-pay options available
The decision should account for: Why Ozempic was prescribed and whether diabetes targets are being met Current dose, time at that dose, and adherence Nausea, vomiting, constipation, reflux, hydration, and nutrition Other glucose-lowering medications and hypoglycemia risk Kidney, gallbladder, pancreatic, eye, and thyroid-related history Whether the apparent plateau is confirmed by a reliable trend If a person is using semaglutide specifically for chronic weight management, a clinician may discuss whether an FDA-approved obesity treatment such as Wegovy, or another medication such as tirzepatide when appropriate, better matches the diagnosis and treatment goals